Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
Revue Medicale De Liege
|
June 1, 1993
[Scintigraphic localization of neuroendocrine tumors and their metastases using a somatostatin analog [111In-DTPA-d-phe1] octreotide]
A Beckers, V T Pham, R Abs, et al.
Acta Neurologica Belgica
|
December 1, 1996
Thyrotoxic periodic paralysis, an unusual cause of hypokalemic periodic paralysis
J Berwaerts, J Verhelst, M Vandenbroucke, et al.
European Journal of Endocrinology
|
December 3, 2005
Glomerular filtration rate in patients with Cushing's disease: a matched case-control study
P Haentjens, L De Meirleir, R Abs, et al.
Lancet (London, England)
|
July 25, 2000
Can growth hormone therapy cause diabetes? KIMS Strategic Committee
J P Monson, B A Bengtsson, R Abs, et al.
Acta Clinica Belgica
|
May 25, 2010
Panhypopituitarism apparently caused by hypophysitis masking a rapid development of a craniopharyngioma. A case report
P Joosen, P Abrams, J Verhelst, et al.
European Journal of Endocrinology
|
September 1, 1995
Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: superiority of continuous versus intermittent administration to control hormonal secretion
S Lefebvre, L De Paepe, R Abs, et al.
Acta Endocrinologica
|
March 1, 1990
Hypoglycemia owing to inappropriate glucagon secretion treated with a continuous subcutaneous glucagon infusion system
R Abs, L Verbist, M Moeremans, et al.
Progress in Histochemistry and Cytochemistry
|
January 1, 1992
Corticotropin-releasing hormone receptors on human pituitary cells: autoradiography at the light microscopical level, quantification and immunocytochemistry
G Smets, J Van Gompel, C Meyer, et al.
Endocrine Pathology
|
May 7, 2020
Failure of total hypophysectomy to remove intrasellar microadenoma in cushing's disease
J Verhelst, R Klaes, G Smets, et al.
European Journal of Endocrinology
|
September 15, 2004
Efficacy and tolerability of lanreotide Autogel therapy in acromegalic patients previously treated with octreotide LAR
O Alexopoulou, P Abrams, J Verhelst, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
Revue Medicale De Liege
|
June 1, 1993
[Scintigraphic localization of neuroendocrine tumors and their metastases using a somatostatin analog [111In-DTPA-d-phe1] octreotide]
A Beckers, V T Pham, R Abs, et al.
Acta Neurologica Belgica
|
December 1, 1996
Thyrotoxic periodic paralysis, an unusual cause of hypokalemic periodic paralysis
J Berwaerts, J Verhelst, M Vandenbroucke, et al.
European Journal of Endocrinology
|
December 3, 2005
Glomerular filtration rate in patients with Cushing's disease: a matched case-control study
P Haentjens, L De Meirleir, R Abs, et al.
Lancet (London, England)
|
July 25, 2000
Can growth hormone therapy cause diabetes? KIMS Strategic Committee
J P Monson, B A Bengtsson, R Abs, et al.
Acta Clinica Belgica
|
May 25, 2010
Panhypopituitarism apparently caused by hypophysitis masking a rapid development of a craniopharyngioma. A case report
P Joosen, P Abrams, J Verhelst, et al.
European Journal of Endocrinology
|
September 1, 1995
Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: superiority of continuous versus intermittent administration to control hormonal secretion
S Lefebvre, L De Paepe, R Abs, et al.
Acta Endocrinologica
|
March 1, 1990
Hypoglycemia owing to inappropriate glucagon secretion treated with a continuous subcutaneous glucagon infusion system
R Abs, L Verbist, M Moeremans, et al.
Progress in Histochemistry and Cytochemistry
|
January 1, 1992
Corticotropin-releasing hormone receptors on human pituitary cells: autoradiography at the light microscopical level, quantification and immunocytochemistry
G Smets, J Van Gompel, C Meyer, et al.
Endocrine Pathology
|
May 7, 2020
Failure of total hypophysectomy to remove intrasellar microadenoma in cushing's disease
J Verhelst, R Klaes, G Smets, et al.
European Journal of Endocrinology
|
September 15, 2004
Efficacy and tolerability of lanreotide Autogel therapy in acromegalic patients previously treated with octreotide LAR
O Alexopoulou, P Abrams, J Verhelst, et al.
Page
of 8